We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
–
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$18.7M
2
ZTWO icon
F/M 2-Year Investment Grade Corporate Bond ETF
ZTWO
+$18.5M
3
AAPL icon
Apple
AAPL
+$10.2M
4
TFC icon
Truist Financial
TFC
+$9.55M
5
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PH icon
301
Parker-Hannifin
PH
$135B
$876K 0.03%
1,441
-53
-4% -$34.7K
USXF icon
302
iShares ESG Advanced MSCI USA ETF
USXF
$1.49B
$848K 0.03%
18,168
– –
SYRE icon
303
Spyre Therapeutics
SYRE
$9.25B
$837K 0.03%
51,844
+3,038
+6% +$63.2K
VXF icon
304
Vanguard Extended Market ETF
VXF
$31.7B
$818K 0.03%
4,748
-70
-1% -$13.2K
UTHR icon
305
United Therapeutics
UTHR
$23.1B
$785K 0.03%
2,547
+143
+6% +$49K
KR icon
306
Kroger
KR
$34.8B
$785K 0.03%
12,000
+800
+7% +$50.7K
EMR icon
307
Emerson Electric
EMR
$88.3B
$777K 0.03%
7,090
-226
-3% -$27.2K
VB icon
308
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$774K 0.03%
3,493
+188
+6% +$44.9K
TDTT icon
309
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
$769K 0.03%
31,528
– –
IJH icon
310
iShares Core S&P Mid-Cap ETF
IJH
$127B
$696K 0.03%
11,935
-207
-2% -$12.9K
PAA icon
311
Plains All American Pipeline
PAA
$16.1B
$694K 0.03%
34,686
– –
VCSH icon
312
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$684K 0.03%
8,671
-95
-1% -$7.45K
SPMD icon
313
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
$673K 0.03%
13,143
-121
-0.9% -$6.6K
SHY icon
314
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$630K 0.03%
7,610
-120
-2% -$9.87K
SVRA icon
315
Savara
SVRA
$1.19B
$618K 0.02%
223,016
+141,673
+174% +$391K
TFC icon
316
Truist Financial
TFC
$64B
$609K 0.02%
14,748
-214,338
-94% -$9.55M
NVCR icon
317
NovoCure
NVCR
$1.91B
$608K 0.02%
34,099
+1,999
+6% +$45.4K
OFIX icon
318
Orthofix Medical
OFIX
$419M
$605K 0.02%
37,122
+10,722
+41% +$188K
GSG icon
319
iShares S&P GSCI Commodity-Indexed Trust
GSG
$968M
$596K 0.02%
26,166
– –
KALV
320
DELISTED
KalVista Pharmaceuticals
KALV
$578K 0.02%
+50,097
New +$511K
IWO icon
321
iShares Russell 2000 Growth ETF
IWO
$15.1B
$576K 0.02%
2,254
-1,000
-31% -$282K
PM icon
322
Philip Morris
PM
$295B
$567K 0.02%
3,572
– –
CL icon
323
Colgate-Palmolive
CL
$74.4B
$546K 0.02%
5,824
+147
+3% +$13.2K
HLNE icon
324
Hamilton Lane
HLNE
$5.57B
$544K 0.02%
3,660
+1,646
+82% +$251K
AB icon
325
AllianceBernstein
AB
$3.47B
$516K 0.02%
13,465
– –
11 12
13
14 15

Similar funds

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.